The reformulated vaccine advisory committee convened today and tomorrow with the intention of making significant changes to children’s access to vaccines. The primary focus of today’s meeting is the elimination of the birth dose of the Hepatitis B vaccine. The Washington Post editorial accurately predicted the outcome of the meeting, dubbing it the “CDC’s next anti-vaccine clown show.”
Robert F. Kennedy Jr. made headlines when he dismissed all 17 experts on the CDC’s vaccine advisory committee on June 9. These experts, who had years of experience and had undergone thorough vetting by the CDC, were replaced by individuals hand-picked by Kennedy himself. Many of these new members have a history of opposing vaccines and promoting discredited research. The American Academy of Pediatrics even boycotted the committee’s June meeting due to concerns over the new members.
The birth dose of the Hepatitis B vaccine has been instrumental in reducing the incidence of acute hepatitis B since its introduction in 1991. Chronic hepatitis B cases have plummeted by 99% thanks to this vaccination. The American Public Health Association credits the universal HBV birth dose with preventing over 500,000 childhood infections and an estimated 90,100 childhood deaths.
The new vaccine advisory group is pushing for a risk-based approach, suggesting that only infants born to mothers with hepatitis B infections receive the birth dose. However, this strategy has been proven ineffective as it fails to account for other sources of infection and transmission. Hepatitis B can survive on contaminated objects for up to a week, making it crucial to vaccinate newborns for protection.
Some committee members argue against delaying the birth dose, citing a study that shows even short delays in vaccination can lead to more infections, severe health complications, and increased healthcare costs. Nurse Teri Mills of Grandparents for Vaccines warns that eliminating the newborn hepatitis B dose will result in unnecessary suffering for the next generation of babies.
In an opinion piece, former CDC directors Drs. Demetre Daslakakis, Daniel Jernigan, and Debra Houry emphasize the importance of maintaining the hepatitis B birth dose to ensure the stability of the childhood vaccination schedule. They caution against raising hypothetical risks while ignoring the real benefits of timely vaccination. The committee must prioritize rigorous science and public health benefits to safeguard the nation’s health system.
